Douglas Ross

2022

In 2022, Douglas Ross earned a total compensation of $1.1M as Former Chief Science Officer at Oncocyte Corp, a 30% decrease compared to previous year.

Compensation breakdown

Option Awards$186,990
Salary$359,135
Stock Awards$201,750
Other$400,775
Total$1,148,649

Ross received $400.8K in other compensation, accounting for 35% of the total pay in 2022.

Ross also received $187K in option awards, $359.1K in salary and $201.8K in stock awards.

Rankings

In 2022, Douglas Ross' compensation ranked 2,759th out of 5,683 executives tracked by ExecPay. In other words, Ross earned more than 51.5% of executives.

ClassificationRankingPercentile
All
2,759
out of 5,683
52nd
Division
Manufacturing
1,531
out of 3,091
51st
Major group
Chemicals And Allied Products
710
out of 1,406
50th
Industry group
Drugs
662
out of 1,307
49th
Industry
In Vitro and In Vivo Diagnostic Substances
12
out of 29
59th
Source: SEC filing on May 19, 2023.

Ross' colleagues

We found five more compensation records of executives who worked with Douglas Ross at Oncocyte Corp in 2022.

2022

Ronald Andrews

Oncocyte Corp

Chief Executive Officer

2022

Gisela Paulsen

Oncocyte Corp

Chief Operating Officer

2022

Anish John

Oncocyte Corp

Chief Financial Officer

2022

Joshua Riggs

Oncocyte Corp

Chief Executive Officer

2022

James Liu

Oncocyte Corp

Controller and Principal Accounting Officer

News

You may also like